GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals NSCLC
Junshi’s PD-1 Antibody Meets Endpoint In Phase 3 Lung Cancer Trial
2023-01-19
Trials & Approvals RSV vaccines
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Trials & Approvals Alzheimer's Disease
Eisai and Biogen’s Alzheimer’s Med, Leqembi, Granted FDA Approval
2023-01-09
Trials & Approvals IgA Nephropathy
Vera Therapeutics Eyes Phase 3 For Kidney Disease Candidate Following Positive Data
2023-01-04
COVID-19 COVID-19 Vaccine
Novavax Begins Phase 2 For COVID-19/Influenza Combination And Stand-Alone Flu Shots
2023-01-03
Special FDA Approval
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
Trials & Approvals Hemophilia B
Pfizer’s Hemophilia B Gene Therapy Meets Phase 3 Endpoints
2022-12-30
Trials & Approvals Multiple Sclerosis
TG Notches FDA Victory For CD20 Antibody For Multiple Sclerosis
2022-12-29
Trials & Approvals FDA Approval
Acer Snags First-Ever FDA Approval With Relief-Partnered Olpruva
2022-12-28
Trials & Approvals Breast Cancer
Immutep Expands Patient Population For LAG-3 Candidate After FDA Meeting
2022-12-26
Trials & Approvals Lunsumio
Roche’s Lunsumio Lands FDA Approval for Pretreated Follicular Lymphoma
2022-12-26
Trials & Approvals Duchenne Muscular Dystrophy-dmd
Entrada Hit With Clinical Hold on IND Application for Muscular Dystrophy Therapy
2022-12-20
Trials & Approvals NSCLC
Gilead, Arcus’ Anti-TIGIT Combinations Show Survival Advantage Over Anti-PD1 Monotherapy In Phase 2 Trial
2022-12-20
Trials & Approvals Astellas Pharma
Astellas’ Zolbetuximab Meets Phase 3 Endpoints In Gastric And GEJ Cancers
2022-12-16
Trials & Approvals NSCLC
Mirati Wins FDA Accelerated Approval For Lung Cancer Mutation
2022-12-14
1 … 5 6 7 8 9 … 50
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top